BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 28145904)

  • 1. Overcoming therapeutic resistance in glioblastoma: the way forward.
    Osuka S; Van Meir EG
    J Clin Invest; 2017 Feb; 127(2):415-426. PubMed ID: 28145904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of octamer binding transcription factors in glioblastoma multiforme.
    Rooj AK; Bronisz A; Godlewski J
    Biochim Biophys Acta; 2016 Jun; 1859(6):805-11. PubMed ID: 26968235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies targeting glioblastoma stem cells.
    Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
    Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cells in glioblastoma.
    Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
    Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
    Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
    Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive profile of recurrent glioblastoma.
    Campos B; Olsen LR; Urup T; Poulsen HS
    Oncogene; 2016 Nov; 35(45):5819-5825. PubMed ID: 27041580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies for inhibiting invasion in glioblastoma.
    Drappatz J; Norden AD; Wen PY
    Expert Rev Neurother; 2009 Apr; 9(4):519-34. PubMed ID: 19344303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognizing and correcting failures in glioblastoma treatment.
    Shah AH; Graham R; Bregy A; Thambuswamy M; Komotar RJ
    Cancer Invest; 2014 Jul; 32(6):299-302. PubMed ID: 24766304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.
    Landis CJ; Tran AN; Scott SE; Griguer C; Hjelmeland AB
    Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):175-188. PubMed ID: 29378228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of cancer stem cell and tumorigenesis.
    Zhu K; Xie V; Huang S
    Adv Cancer Res; 2020; 148():1-26. PubMed ID: 32723561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain tumor stem cells].
    Hide T; Makino K; Nakamura H; Yano S; Kuratsu J
    Nihon Rinsho; 2015 May; 73(5):836-43. PubMed ID: 25985640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Mesenchymal Reprogramming in Malignant Clonal Evolution and Intra-Tumoral Heterogeneity in Glioblastoma.
    Wu Q; Berglund AE; Macaulay RJ; Etame AB
    Cells; 2024 May; 13(11):. PubMed ID: 38891074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma cancer stem cells--from concept to clinical application.
    Stopschinski BE; Beier CP; Beier D
    Cancer Lett; 2013 Sep; 338(1):32-40. PubMed ID: 22668828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma cancer stem cells: Biomarker and therapeutic advances.
    Pointer KB; Clark PA; Zorniak M; Alrfaei BM; Kuo JS
    Neurochem Int; 2014 May; 71():1-7. PubMed ID: 24657832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma.
    Hoffman M; Gillmor AH; Kunz DJ; Johnston MJ; Nikolic A; Narta K; Zarrei M; King J; Ellestad K; Dang NH; Cavalli FMG; Kushida MM; Coutinho FJ; Zhu Y; Luu B; Ma Y; Mungall AJ; Moore R; Marra MA; Taylor MD; Pugh TJ; Dirks PB; Strother D; Lafay-Cousin L; Resnick AC; Scherer S; Senger DL; Simons BD; Chan JA; Morrissy AS; Gallo M
    Cancer Res; 2019 May; 79(9):2111-2123. PubMed ID: 30877103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution.
    Kim H; Zheng S; Amini SS; Virk SM; Mikkelsen T; Brat DJ; Grimsby J; Sougnez C; Muller F; Hu J; Sloan AE; Cohen ML; Van Meir EG; Scarpace L; Laird PW; Weinstein JN; Lander ES; Gabriel S; Getz G; Meyerson M; Chin L; Barnholtz-Sloan JS; Verhaak RG
    Genome Res; 2015 Mar; 25(3):316-27. PubMed ID: 25650244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.